In this study, we assessed whether CYP1A1 levels were elevated in prostate cancer compared to normal prostate or benign prostatic hyperplasia (BPH) using tissue microarray (TMA) of human specimens as well as prostatic cell lines (cancer versus BPH-1). This evidence concerns the gene CYP1A1 and cancer.